Publicacions en què col·labora amb MARÍA ÁNGELES ORELLANA MIGUEL (15)

2024

  1. Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324

2023

  1. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  2. Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial

    BMJ open, Vol. 13, Núm. 9, pp. e072121

2021

  1. Eradication of staphylococcus aureus post-sternotomy mediastinitis following the implementation of universal preoperative nasal decontamination with mupirocin: An interrupted time-series analysis

    Clinical Infectious Diseases, Vol. 73, Núm. 9, pp. 1685-1692

2020

  1. Impact of duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 10, pp. 3049-3055

2019

  1. A short course of antibiotic treatment is safe after catheter withdrawal in catheter-related bloodstream infections due to coagulase-negative staphylococci

    European Journal of Clinical Microbiology and Infectious Diseases

2018

  1. Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test

    Clinical Microbiology and Infection, Vol. 24, Núm. 4, pp. 414-421

2017

  1. Listeria monocytogenes bacteraemia over an 11-year period: Clinical and epidemiologic characteristics in the south area of Madrid

    Journal of Infection

  2. Pathogen-related factors affecting outcome of catheter-related bacteremia due to methicillin-susceptible Staphylococcus aureus in a Spanish multicenter study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 10, pp. 1757-1765

  3. Therapeutisches Verhalten bei asymptomatischer Bakteriurie von Nierentransplantierten

    Nieren- und Hochdruckkrankheiten

2016

  1. High MICs for vancomycin and daptomycin and complicated catheter-related bloodstream infections with methicillin-sensitive Staphylococcus aureus

    Emerging Infectious Diseases, Vol. 22, Núm. 6, pp. 1057-1066

  2. Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options

    Transplant Infectious Disease, Vol. 18, Núm. 4, pp. 575-584

  3. Should asymptomatic bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial

    American Journal of Transplantation, Vol. 16, Núm. 10, pp. 2943-2953

2015

  1. Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case–control study

    Infection, Vol. 43, Núm. 4, pp. 413-422

  2. Risk factors for metastatic osteoarticular infections after a long follow-up of patients with Staphylococcus aureus bacteraemia

    Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1010.e1-1010.e5